Montreal Neurological Institute and Hospital news
Multidisciplinary care and cutting-edge research share space at The Neuro The Montreal Neurological Institute and Hospital (The Neuro) is recognized worldwide for its research and clinical expertise in Parkinson’s disease (PD). PD is a motor neuron disease that is generally associated with old age, but people can also develop it in their thirties and forties. Characteristic symptoms include tremor, rigidity and gait dysfunction, mood and sleep disorders, and cognitive degeneration. About 100,000 Canadians have PD.
March 26 is Purple Day for Epilepsy, a day to support epilepsy awareness worldwide The Neuro has been a world leader in epilepsy treatment and research for more than 60 years. Indeed, the “Montreal Procedure” developed by The Neuro’s founder, Dr. Wilder Penfield, and his colleagues has become the standard operating procedure for the surgical treatment of epilepsy. The Neuro was also a pioneering institute in exploiting electroencephalography (EEG) and magnetic resonance imaging (MRI) to study and treat epilepsy.
McGill Newsroom 3D depth-sensing camera shown to measure walking difficulties A commonly used device found in living rooms around the world could be a cheap and effective means of evaluating the walking difficulties of multiple sclerosis (MS) patients. The Microsoft Kinect is a 3D depth-sensing camera used in interactive video activities such as tennis and dancing. It can be hooked up to an Xbox gaming console or a Windows computer.
McGill Newsroom Neuron cell death may be caused by overactive immune system A team of scientists led by Dr. Michel Desjardins from the University of Montreal and Dr. Heidi McBride from the Montreal Neurological Institute and Hospital (MNI) at McGill University have discovered that two genes associated with Parkinson's disease (PD) are key regulators of the immune system, providing direct evidence linking Parkinson's to autoimmune disease.
By Shawn Hayward, Montreal Neurological Institute and Hospital Discovery will aid development of treatments for this debilitating disease Scientists at the Montreal Neurological Institute and Hospital (MNI) have identified novel gene mutations that cause hereditary spastic paraplegia (HSP), a step forward in efforts to treat this debilitating disease.
By Shawn Hayward, Montreal Neurological Institute Discovery will inform further research into hearing disorders and brain training Scientists at the Montreal Neurological Institute and Hospital at McGill University have made an important discovery about the human auditory system and how to study it, findings that could lead to better testing and diagnosis of hearing-related disorders.
By Maya-Olivia Eyssen, Montreal Neurological Institute and Hospital Montreal high school students to take part in brain quiz.
November 19 marks the 50th anniversary of the ground-breaking paper, “Pain Mechanisms: A New Theory” co-authored by McGill’s Ronald Melzack, and the late Patrick Wall, which introduced gate-control theory.
Discovery provides new tool for understanding and treating neurodegenerative diseases
Researchers get inaugural Foundation grants for high-impact, long-term programs Researchers from the Montreal Neurological Institute and Hospital, McGill University have been awarded over $15 million in grants in the latest round of funding by the Canadian Institutes of Health Research (CIHR). The grants are part of over $600 million in national funding, announced July 28 by Minister of Health Rona Ambrose.
Study fuels nature versus nurture debate How do you get to Carnegie Hall? New research on the brain’s capacity to learn suggests there’s more to it than the adage that “practise makes perfect.” A music-training study by scientists at the Montreal Neurological Institute and Hospital -The Neuro, at McGill University and colleagues in Germany found evidence to distinguish the parts of the brain that account for individual talent from the parts that are activated through training.
Time is brain: for every minute a stroke is left untreated, 2 million brain cells are destroyed. The sooner patients are treated, the higher the chances of survival with fewer disabilities. Patients with acute strokes and transient ischemic attack (TIA) are assessed and treated at the right place, the right time and by the right professionals thanks to ultra-specialized stroke centres at the Montreal General Hospital and The Montreal Neurological Institute and Hospital.
Researchers from the Montreal Neurological Institute and Hospital at McGill University and the MUHC, have received a total of over $4.5 M in funding, for innovative projects to accelerate diagnosis and drug discovery for diseases of the brain, including Alzheimer’s. CQDM, Brain Canada Foundation and the Ontario Brain Institute made the announcement at the annual conference of the Canadian Association for Neuroscience in Vancouver. Six Canadian research teams share a total investment of $ 10 million, through the strategic "Focus on Brain" initiative.
Researchers pinpoint a brain area that influences electoral decisions